← Leaderboards
Pari Vijay Pandharipande
Ohio State University
$4,201,518
Attributed
$5,331,870
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,331,870 · 3
By mechanism
R01$4,440,433 · 2
K07$891,437 · 1
Top collaborators
- Jason Wright5 shared
Most similar at Ohio State University
Same institution · by research overlap
- Somashekar G. Krishna$1,255,444
- Spero R. Cataland$799,854
Others in their field
Top investigators on “Cost”
- Eric S Lander · Whitehead Institute For Biomedical Res$748,368,930
- Richard K. Wilson · Washington University$429,230,873
- Richard A Gibbs · Baylor College Of Medicine$414,258,216
- David R. Weir · University Of Michigan At Ann Arbor$393,741,481
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
Research focus
CostOperative Surgical ProceduresComorbidityFutureDiagnosisWomen&AposCost EffectiveCessation Of LifeSeer ProgramData SourcesRecommendationHarm ReductionPersonalized ApproachAffectPreventMedicareCancer EtiologyModels And SimulationLife ExpectancyCancer CareMathematical ModelCharacteristicsPublishingDisease Model
Grant awards (16)
Improving Treatment Selection in Advanced Ovarian Cancer$480,691
R01 · FY2025 · CA · contact PI
Improving Treatment Selection in Advanced Ovarian Cancer$76,654
R01 · FY2025 · CA · contact PI
Improving Treatment Selection in Advanced Ovarian Cancer$530,073
R01 · FY2024 · CA · contact PI
Precision Management of Cystic Precursors to Pancreatic Cancer$394,049
R01 · FY2024 · CA · contact PI
Improving Treatment Selection in Advanced Ovarian Cancer$532,652
R01 · FY2023 · CA · contact PI
Improving Treatment Selection in Advanced Ovarian Cancer$640,635
R01 · FY2022 · CA · contact PI
Precision Management of Cystic Precursors to Pancreatic Cancer$436,460
R01 · FY2022 · CA · contact PI
Precision Management of Cystic Precursors to Pancreatic Cancer$314,557
R01 · FY2021 · CA · contact PI
Precision Management of Cystic Precursors to Pancreatic Cancer$129,205
R01 · FY2021 · CA · contact PI
Precision Management of Cystic Precursors to Pancreatic Cancer$427,682
R01 · FY2020 · CA · contact PI
Precision Management of Cystic Precursors to Pancreatic Cancer$477,775
R01 · FY2019 · CA · contact PI
Cost-Effectiveness of Radiofrequency Ablation for Small, Incidental Renal Tumors$177,555
K07 · FY2013 · CA · contact PI
Cost-Effectiveness of Radiofrequency Ablation for Small, Incidental Renal Tumors$178,148
K07 · FY2012 · CA · contact PI
Cost-Effectiveness of Radiofrequency Ablation for Small, Incidental Renal Tumors$178,817
K07 · FY2011 · CA · contact PI
Cost-Effectiveness of Radiofrequency Ablation for Small, Incidental Renal Tumors$178,260
K07 · FY2010 · CA · contact PI
Cost-Effectiveness of Radiofrequency Ablation for Small, Incidental Renal Tumors$178,657
K07 · FY2009 · CA · contact PI